Sharemaestro Newsreel

GE Healthcare Technologies Inc (GEHC) Stock News Today

This article provides recent stock news for GE Healthcare Technologies Inc (GEHC), highlighting its stock performance and key financial metrics. It also references related news for other healthcare companies like CVS Health Corp, Medtronic PLC, and Intuitive Surgical Inc, indicating market movements on April …

Is Medtronic (MDT) Becoming a Turnaround Story?

UBS upgraded Medtronic (NYSE:MDT) to a Buy from Neutral today, telling investors in a research note that a "turnaround" is underway at the company. The upgrade raises an important question for investors: Is Medtronic finally returning to sustainable growth after years of underperformance, or …

Haemonetics Corporation (HAE) Stock forecasts

Argus has raised its target price for Haemonetics Corporation (HAE) stock to $90.00. The company, currently trading at $86.61, focuses on improving patient care and reducing healthcare costs through its medical products and solutions for blood and plasma collection, surgical suites, and hospital transfusion …

Stryker Corp (SYK.DU) Analyst insights, Price targets and Recommendations

This article provides an overview of analyst ratings and recommendations for Stryker Corp (SYK.DU). It lists recent analyst actions including upgrades, downgrades, and maintains, with specific firms and their assigned ratings and dates. The information is presented in a concise format to quickly convey …

Cytosorbents Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CTSO) 2026-08-09

This document contains the Q2 2026 earnings call transcript for Cytosorbents Corp (NAS:CTSO), held on August 6, 2026. Key points from the call indicate a significant reduction in operating cash burn, improved gross margins, and growth in the distributor network revenue. However, challenges include …

Sei Investments Co. Buys 448,174 Shares of Apyx Medical Corporation $APYX

Sei Investments Co. significantly increased its stake in Apyx Medical Corporation by 298.6% during the first quarter, purchasing an additional 448,174 shares to bring its total holdings to 598,255 shares, valued at $2.208 million. This move is part of broader institutional interest, with such …

Bio Rad Laboratories (BIO) Earnings And Guidance Put Fair Value Back In Focus

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Q2 earnings and new guidance put Bio-Rad Laboratories in focus Bio-Rad Laboratories (BIO) drew investor attention after reporting second quarter 2026 results alongside …

VREX Looks 11.5% Undervalued on GF Value™ as It Prepares Q3 Earnings

Varex Imaging Corp (VREX) is set to release its Q3 earnings on August 10, with analysts forecasting increased EPS and revenue. Despite facing profitability and cash flow challenges, the company appears 11.5% undervalued according to GuruFocus' GF Value™ metric, though this should be interpreted …

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief …

Kraken Delisting Deadline Nears: Holders of 21 Tokens Risk Near-Zero Payouts

kraken delisting. Photo by BeInCrypto Kraken is entering the final stage of its latest delisting cycle, giving holders of 21 tokens until August 27 at 14:00 UTC to withdraw their assets. Afterwards, the exchange begins automatically liquidating remaining balances into markets it warns may …

Assenagon Asset Management S.A. Has $46.72 Million Holdings in DexCom, Inc. $DXCM

Assenagon Asset Management S.A. significantly reduced its stake in DexCom, Inc. by 59.7% in the second quarter, now holding 693,635 shares valued at $46.72 million. Despite this, institutional investors collectively own 97.75% of DXCM, and analysts generally maintain a "Moderate Buy" rating with an …

Sensus Healthcare Inc expected to post a loss of 9 cents a share - Earnings Preview

Sensus Healthcare Inc (SRTS) is anticipated to report a loss of 9 cents per share for the period ending September 30, 2025, with revenue expected to fall by 28.6% to $6.313 million. Despite the projected loss and revenue decrease, analysts currently rate the shares …

(CVRX) Price Dynamics and Execution-Aware Positioning

This article provides an AI-driven analysis of Cvrx Inc. (NASDAQ: CVRX), highlighting weak sentiment across all horizons and a short bias. It details institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels. …

Zimmer Biomet Q2 Earnings Call Highlights

Key Points Interested in Zimmer Biomet Holdings, Inc.? Here are five stocks we like better. Zimmer Biomet reported solid Q2 growth: Net sales rose 4.8% to $2.177 billion, driven by hips, specialty businesses and technology. Adjusted EPS was $2.07, while U.S. organic sales increased …

Why AdaptHealth Stock Plummeted This Week

Key Points AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.10 stocks we like better than AdaptHealth › AdaptHealth(NASDAQ: AHCO) stock got crushed this week after the …

NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Nano-X Imaging Ltd. (NASDAQ:NNOX) on behalf of investors who purchased securities between March 31, 2025, and April 17, 2026. The lawsuit alleges that Nano-X made materially false and misleading statements regarding its …

Pacific Biosciences of California, Inc. $PACB Shares Sold by Renaissance Technologies LLC

Renaissance Technologies LLC significantly reduced its stake in Pacific Biosciences of California (NASDAQ:PACB) by 35.4% in the first quarter, selling 1,361,500 shares. This comes as analyst sentiment for PACB is generally bearish, with an average "Reduce" rating and an average price target of $1.83. …

Nano-X Imaging Raises $8 Million in Registered Direct Offering Completed on August 7, 2026

Nano-X Imaging (NNOX) announced the completion of an $8 million registered direct offering on August 7, 2026, to a single institutional investor. The company issued 8 million ordinary shares or pre-funded warrants along with 8 million purchase warrants, with proceeds intended for working capital …

Enovis (ENOV) Reaffirmed Guidance And Improved Margins, Is The Stock Still Undervalued?

Enovis (ENOV) reaffirmed its full-year 2026 revenue guidance and reported improved Q2 results, including organic growth and margin improvement, leading to a smaller net loss. Despite recent stock performance showing some momentum, the company is still considered undervalued by analysts, trading below the fair …

PROCEPT BioRobotics Corporation Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Affected PRCT Investor Summary Who: PROCEPT BioRobotics Corporation (NASDAQ: PRCT)What: Securities fraud class action lawsuit filedClass Period: February 28, 2024 through February 25, 2026Deadline to Seek Lead Plaintiff Status: September 22, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s product demandInvestor Action: …

IRADIMED CORPORATION (NASDAQ:IRMD) Looks Interesting, And It's About To Pay A Dividend

TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - TMDX

A class action securities lawsuit has been filed against TransMedics Group, Inc. (NASDAQ:TMDX) on behalf of investors who suffered losses between February 28, 2023, and January 10, 2025. The lawsuit alleges that TransMedics made false statements and concealed practices such as kickbacks, fraudulent overbilling, …

CVRx, Inc. (NASDAQ:CVRX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

CVRx, Inc. (NASDAQ:CVRX) experienced a significant share price drop of 54% following its second-quarter results, which met revenue expectations but reported wider losses than anticipated. Analysts have subsequently lowered their revenue forecasts for 2026 and increased their per-share loss expectations, leading to a 47% …

Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67

Inogen, Inc. (NASDAQ:INGN) reported quarterly results last week, with revenues of US$95m matching predictions and statutory losses coming in 8.7% smaller than expected at US$0.14 per share. Following the report, analysts reconfirmed their loss per share estimates for next year but downgraded revenue estimates, …

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important …

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to ...

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to join a class action lawsuit. The lawsuit alleges that PROCEPT made materially false and misleading statements about an extensive discount program which artificially inflated reported sales and revenue between February …

Bank of America Corp DE Sells 46,436 Shares of Penumbra, Inc. $PEN

Bank of America Corp DE reduced its stake in Penumbra, Inc. by 15.2% in the first quarter, selling 46,436 shares and retaining 259,775 shares valued at approximately $85.3 million. Despite Penumbra reporting a 14.9% year-over-year revenue increase to $390.05 million, its earnings per share …

Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Zimmer Biomet Holdings, Inc. (ZBH) stock, including its current price, news, and historical data. It notes a recent downgrade by BTIG due to growth challenges and presents performance metrics against the S&P 500. The article …

CVRx Falls To US$2.39, But Insiders Sold At Lower Price

The article discusses CVRx's recent stock price decline to US$2.39, highlighting that while the stock has fallen, insiders had sold shares at an even lower price of US$2.05 in the past year. This insider selling activity, despite the lower price point, raises questions about …

US$2.88: That's What Analysts Think Cytosorbents Corporation (NASDAQ:CTSO) Is Worth After Its Latest Results

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus

Wall Street’s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P …

PensionDanmark Pensionsforsikringsaktieselskab Has $6.24 Million Stake in GE HealthCare Technologies Inc. $GEHC

PensionDanmark Pensionsforsikringsaktieselskab significantly increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 39.7% in the second quarter, bringing its total holdings to 97,524 shares valued at approximately $6.24 million. Other institutional investors also adjusted their positions in the company, which reported strong quarterly …

Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more

[Business Person Reviewing Quarterly Report During Meeting in Office Setting] The second full week of August features a diverse earnings slate spanning AI infrastructure, semiconductors, space technology, healthcare, financials, and consumer names, with Super Micro Computer (SMCI [https://seekingalpha.com/symbol/SMCI]), Nebius (NBIS [https://seekingalpha.com/symbol/NBIS]), Cisco Systems (CSCO …

Should You Investigate Enovis Corporation (NYSE:ENOV) At US$26.61?

This article evaluates Enovis Corporation's (NYSE:ENOV) stock at its current price of US$26.61. It will likely delve into financial metrics, analyst sentiment, and market conditions to determine if it's an attractive investment opportunity.

Is Haemonetics (HAE) Undervalued As Q1 Earnings And Outlook Lift Optimism?

Establishment Labs (ESTA) Stock Looks Fair On Cash Flow Yet Trades At A Premium On Sales